HS

HighVista Strategies Portfolio holdings

AUM $272M
1-Year Est. Return 24.34%
This Quarter Est. Return
1 Year Est. Return
+24.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$260M
AUM Growth
-$9.28M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
172
New
Increased
Reduced
Closed

Top Buys

1 +$2.06M
2 +$2.03M
3 +$2.03M
4
MMM icon
3M
MMM
+$1.98M
5
MTZ icon
MasTec
MTZ
+$1.9M

Top Sells

1 +$4.45M
2 +$2.95M
3 +$2.23M
4
LYV icon
Live Nation Entertainment
LYV
+$2.02M
5
INDV icon
Indivior
INDV
+$1.83M

Sector Composition

1 Healthcare 39.15%
2 Technology 17.75%
3 Industrials 8.61%
4 Consumer Discretionary 6.17%
5 Financials 5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBC icon
1
Invesco DB Commodity Index Tracking Fund
DBC
$1.25B
$32.3M 12.45%
1,436,136
HES
2
DELISTED
Hess
HES
$4.62M 1.78%
28,900
JNPR
3
DELISTED
Juniper Networks
JNPR
$4.15M 1.6%
114,700
ACI icon
4
Albertsons Companies
ACI
$10.8B
$4.15M 1.6%
188,753
ANSS
5
DELISTED
Ansys
ANSS
$4.05M 1.56%
12,800
PTGX icon
6
Protagonist Therapeutics
PTGX
$4.82B
$3.79M 1.46%
78,452
+15,934
MSFT icon
7
Microsoft
MSFT
$3.82T
$3.66M 1.41%
9,758
-800
AMED
8
DELISTED
Amedisys
AMED
$3.64M 1.4%
39,250
AMZN icon
9
Amazon
AMZN
$2.27T
$3.56M 1.37%
18,693
-15,500
ACLX icon
10
Arcellx
ACLX
$4.82B
$3.12M 1.2%
47,496
+3,692
DVAX icon
11
Dynavax Technologies
DVAX
$1.15B
$3.05M 1.18%
235,172
-63,364
SWTX
12
DELISTED
SpringWorks Therapeutics
SWTX
$3.03M 1.17%
68,758
LQDA icon
13
Liquidia Corp
LQDA
$1.94B
$3M 1.16%
203,510
GEV icon
14
GE Vernova
GEV
$163B
$2.99M 1.15%
9,800
+3,000
XPO icon
15
XPO
XPO
$15.3B
$2.89M 1.11%
26,880
+1,100
NUVL icon
16
Nuvalent
NUVL
$6.67B
$2.83M 1.09%
39,876
AVGO icon
17
Broadcom
AVGO
$1.65T
$2.66M 1.03%
15,900
+6,800
RVMD icon
18
Revolution Medicines
RVMD
$10.1B
$2.61M 1%
73,752
+16,506
AXSM icon
19
Axsome Therapeutics
AXSM
$6.38B
$2.51M 0.97%
21,503
+4,379
CRM icon
20
Salesforce
CRM
$231B
$2.49M 0.96%
9,285
-300
VRDN icon
21
Viridian Therapeutics
VRDN
$1.98B
$2.43M 0.94%
180,551
+25,988
APLS icon
22
Apellis Pharmaceuticals
APLS
$3.1B
$2.38M 0.92%
108,714
INTU icon
23
Intuit
INTU
$184B
$2.37M 0.91%
3,863
+1,300
ALKS icon
24
Alkermes
ALKS
$5B
$2.34M 0.9%
70,762
+16,316
MRUS icon
25
Merus
MRUS
$7.19B
$2.32M 0.89%
55,039